{
    "title": "U.S. FDA approves drug to treat Duchenne muscular dystrophy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4209692/FDA-approves-Marathon-Pharmaceuticals-DMD-drug.html",
    "date": "2017-02-09",
    "keywords": [
        "drug",
        "marathon",
        "approval",
        "dystrophy",
        "gmt",
        "disease",
        "deflazacort",
        "steroid",
        "fda",
        "price",
        "year",
        "percent",
        "reporting",
        "email",
        "toni",
        "clarkefeb",
        "food",
        "administration",
        "musclewasting",
        "class",
        "conditionsemflaza",
        "prednisone",
        "emflaza",
        "side",
        "prednisonedeflazacort",
        "decadesthe",
        "issue",
        "use",
        "product",
        "company",
        "assistance",
        "program",
        "disorder",
        "muscle",
        "deterioration",
        "age",
        "janet",
        "woodcock",
        "head",
        "fdas",
        "division",
        "opposition",
        "agencys",
        "recommendation",
        "panel",
        "dmd",
        "subset",
        "thursday",
        "clarke",
        "mukhopadhyay",
        "bengaluru",
        "editing",
        "hay",
        "matthew",
        "lewis"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}